Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis

Journal of Neuroimmunology

Volumn 270, Issue 1-2, 2014, Pages 45-50

  Kim, Tae Joon ^a,b   Lee, Soon Tae ^a,b   Shin, Jung Won ^a,b   Moon, Jangsup ^a,b   Lim, Jung Ah ^a,b   Byun, Jung Ick ^a,b   Shin, Yong Won ^a,b   Lee, Keon Joo ^a,b   Jung, Keun Hwa ^a,b   Kim, Young Soo ^c   Park, Kyung Il ^d   Chu, Kon ^a,b   Lee, Sang Kun ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

Autoimmune synaptic encephalitis; Encephalitis

Indexed keywords

AUTOIMMUNE SYNAPTIC ENCEPHALITIS; ENCEPHALITIS; GABA(B);

AGED; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LIMBIC ENCEPHALITIS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, GABA-B; TREATMENT OUTCOME;

EID: 84898807357     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.02.011     Document Type: Article

References (26)

1. Ances B.M., Vitaliani R., Taylor R.A., Liebeskind D.S., Voloschin A., Houghton D.J., Galetta S.L., Dichter M., Alavi A., Rosenfeld M.R., Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005, 128:1764-1777.
2. Basu S., Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol. Imaging Biol. 2008, 10:131-137.
3. Baumgartner A., Rauer S., Mader I., Meyer P.T. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J. Neurol. 2013, 260:2744-2753.
4. Boronat A., Sabater L., Saiz A., Dalmau J., Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurologic disorders. Neurology 2011, 76:795-800.
5. Collingridge G.L., Isaac J.T., Wang Y.T. Receptor tracking and synaptic plasticity. Nat. Rev. Neurosci. 2004, 5:952-962.
6. Dalmau J., Furneaux H.M., Gralla R.J., Kris M.G., Posner J.B. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative Western blot analysis. Ann. Neurol. 1990, 27:544-552.
7. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74.
8. Fisher R.E., Patel N.R., Lai E.C., Schulz P.E. Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin. Nucl. Med. 2012, 37:e213-e218.
9. Graus F., Keime-Guibert F., Reñe R., Benyahia B., Ribalta T., Ascaso C., Escaramis G., Delattre J.Y. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001, 124:1138-1148.
10. Höftberger R., Titulaer M.J., Sabater L., Dome B., Rózsás A., Hegedus B., Hoda M.A., Laszlo V., Ankersmit H.J., Harms L., Boyero S., de Felipe A., Saiz A., Dalmau J., Graus F. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013, 81:1500-1506.
11. Irani S.R., Buckley C., Vincent A., Cockerell O.C., Rudge P., Johnson M.R., Smith S. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008, 71:1647-1648.
12. Irani S.R., Michell A.W., Lang B., Pettingill P., Waters P., Johnson M.R., Schott J.M., Armstrong R.J.E., Szagami A., Bleasel A., Somerville E.R., Smith S.M.J., Vincent A. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann. Neurol. 2011, 69:892-900.
13. Irani S.R., Bien C.G., Lang B. Autoimmune epilepsies. Curr. Opin. Neurol. 2011, 24:146-153.
14. Kamaleshwaran K.K., Iyer R.S., Antony J., Radhakrishnan E.K., Shinto A. 18F-FDG PET/CT findings in voltage-gated potassium channel limbic encephalitis. Clin. Nucl. Med. 2013, 38:392-394.
15. Lancaster E., Lai M., Peng X., Hughes E., Constantinescu R., Raizer J., Friedman D., Skeen M.B., Grisold W., Kimura A., Ohta K., Iizuka T., Guzman M., Graus F., Moss S.J., Balice-Gordon R., Dalmau J. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010, 9:67-76.
16. Lancaster E., Martinez-Hernandez E., Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011, 77:179-189.
17. Lee B.Y., Newberg A.B., Liebeskind D.S., Kung J., Alavi A. FDG-PET findings in patients with suspected encephalitis. Clin. Nucl. Med. 2004, 29:620-625.
18. Leypoldt F., Buchert R., Kleiter I., Marienhagen J., Gelderblom M., Magnus T., Dalmau J., Gerloff C., Lewerenz J. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J. Neurol. Neurosurg. Psychiatry 2012, 83:681-686.
19. Moscato E.H., Jain A., Peng X., Hughes E.G., Dalmau J., Balice-Gordon R.J. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur. J. Neurosci. 2010, 32:298-309.
20. Park B.S., Kim Y.S., Lee S.T., Jung K.H., Lee S.G., Chu K. Anti-GABA-B receptor autoimmune encephalitis. J. Korean Epilepsy Soc. 2012, 16:59-62.
21. Prosser H.M., Gill C.H., Hirst W.D., Grau E., Robbins M., Calver A., Soffin E.M., Farmer C.E., Lanneau C., Gray J., Schenck E., Warmerdam B.S., Clapham C., Reavill C., Rogers D.C., Stean T., Upton N., Humphreys K., Randall A., Geppert M., Davies C.H., Pangalos M.N. Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol. Cell. Neurosci. 2001, 17:1059-1070.
22. Rey C., Koric L., Guedj E., Felician O., Kaphan E., Boucraut J., Ceccaldi M. Striatal hypermetabolism in limbic encephalitis. J. Neurol. 2012, 259:1106-1110.
23. Shin Y.W., Lee S.T., Shin J.W., Moon J., Lim J.A., Byun J.I., Kim T.J., Lee K.J., Kim Y.S., Park K.I., Jung K.H., Lee S.K., Chu K. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J. Neuroimmunol. 2013, 265:75-81.
24. Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T., Honig L.S., Benseler S.M., Kawachi I., Martinez-Hernandez E., Aguilar E., Gresa-Arribas N., Ryan-Florance N., Torrents A., Saiz A., Rosenfeld M.R., Balice-Gordon R., Graus F., Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013, 12:157-165.
25. Ulrich D., Bettler B. GABA(B) receptors: synaptic functions and mechanisms of diversity. Curr. Opin. Neurobiol. 2007, 17:298-303.
26. Zuliani L., Graus F., Giometto B., Bien C., Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J. Neurol. Neurosurg. Psychiatry 2012, 83:638-645.